AI summary · may contain errors
Perioperative ADT plus apalutamide improved metastasis-free survival and increased pathological complete response or minimal residual disease rates versus ADT plus placebo in 5-year follow-up.
- 2 cited this week
Moving in New England Journal of Medicine.
Rebuilt
AI summary · may contain errors
Perioperative ADT plus apalutamide improved metastasis-free survival and increased pathological complete response or minimal residual disease rates versus ADT plus placebo in 5-year follow-up.
Newest first · last 60 days
AI summary · may contain errors
TPH1-driven serotonin metabolism stabilizes the neuroendocrine prostate cancer plastic state by enabling serotonin-based posttranslational serotonylation of mTOR and activating FOXM1/E2F1.
AI summary · may contain errors
In RB1-deregulated CRPC-NE models, minor spliceosome (MiS) activity—tracked by U6atac—restricts E2F transcriptional programs, with U6atac depletion causing E2F mis-splicing and E2F1-MIRI biomarker translation.
AI summary · may contain errors
XPO5 is linked to advanced prostate cancer progression by promoting ferroptosis resistance through MITF nuclear export and suppression of ACSL4 transcription.
AI summary · may contain errors
Higher circulating immune-surveillance–related proteins, especially those tied to natural killer and T cell activity, are linked to lower prostate cancer risk in EPIC.
AI summary · may contain errors
Small-molecule inhibitors stabilize oligomeric interfaces of the intrinsically disordered androgen receptor activation domain, with mechanisms resolved by long-timescale all-atom MD and NMR.
AI summary · may contain errors
CDK12-knockout prostate cancer cells show an ATM-like DSB response phenotype and are sensitized to ATR inhibition, with combined PARP plus ATR suppressing growth in CDK12-defective patient-derived xenografts.
AI summary · may contain errors
GenSci143, a B7-H3 × PSMA-directed bispecific antibody-drug conjugate, produced profound tumor regression in prostate cancer xenograft models and showed superior antitumor activity versus competitor ADCs.
AI summary · may contain errors
A composite biomarker combining membranous Nectin-4 expression with NECTIN4 gene amplification predicts response to enfortumab vedotin in muscle-invasive or metastatic urothelial cancer.
AI summary · may contain errors
In human prostate tumors, PKA subunits show grade-dependent spatial redistribution—RIβ declines while PKAC shifts into proliferating Grade Group 4 cells—linked to stronger substrate phosphorylation.
AI summary · may contain errors
SPEN inactivation is linked to reduced benefit from androgen receptor pathway inhibitors in metastatic prostate cancer, with shorter time on therapy in large real-world cohorts.
AI summary · may contain errors
A compendium of 3,001 multi-ancestry prostate methylomes identifies four epigenomic subtypes that risk-stratify patients from normal tissue through poly-metastatic disease.
AI summary · may contain errors
In UK registries of 3477 men with nonmetastatic prostate cancer treated with focal HIFU or cryotherapy, 10-year cancer-specific mortality was 0.13% (95% CI 0.027–0.45%).
AI summary · may contain errors
Tumor-derived CTHRC1 promotes osteoclast differentiation in prostate cancer bone metastasis, driving osteolytic lesion development via an ITGB3-dependent mechanism in mouse models.
AI summary · may contain errors
ASCO’s living guideline for systemic therapy in metastatic castration-resistant prostate cancer is continuously updated to reflect rapidly changing evidence and clinical practice needs.
AI summary · may contain errors
Androgen receptor signaling is linked to suppressed adaptive anticancer immunity, and AR inhibition is shown in preclinical cancer models to enhance T cell function and sensitize tumors to immune checkpoint blockade.
AI summary · may contain errors
Enzalutamide plus testosterone suppression improved overall survival versus a first-generation nonsteroidal antiandrogen in metastatic hormone-sensitive prostate cancer, with 8-year OS 50% vs 40% (HR 0.73).
AI summary · may contain errors
Metastatic prostate cancer is linked to immune evasion and progression, with therapy resistance often associated with a castration-resistant state and molecular changes.
AI summary · may contain errors
Intratumoral androstenedione (A4) levels in breast cancer specimens are linked to a 90-gene transcriptional classifier that stratifies patients into low, intermediate, and high A4 groups with different outcomes.
Journals this month
Topics moving, week to 17 Nov 2026
By field